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ABSTRACT 
 
Introduction: The rate of antibiotic resistance in Staphylococcus epidermidis is high. The 
previous study shows that 79% of Staphylococcus epidermidis bacteria isolated were resistant 
to Methicillin, while 98% were resistant to Penicillin. The active substance Curcuminoid in 
Turmeric is known to have an antibacterial effect. Nowadays, nanoparticle-based medicine 
has been developed which can increase bioavailability and solubility in the water, as well as 
the cellular uptake. 
Aim: The study aimed to analyze the inhibitory and killing effect of Curcuminoid from 
Turmeric (Curcuma longa L.) with mesoporous silica nanoparticles against Staphylococcus 
epidermidis 
Methods: This research performs a microdilution test of Curcuminoid with mesoporous silica 
nanoparticles at concentration 2000 – 32000 µg/mL against Staphylococcus epidermidis on 
the microplate. The minimum inhibitory concentration (MIC) and minimum bactericidal 
concentration (MBC) were obtained from its optical density value after evaluating its turbidity 
on the spectrophotometer. 
Results: In this research found the MIC of Curcuminoid with mesoporous silica nanoparticles 
against Staphylococcus epidermidis was at the concentration of 32000 µg/mL. 
Conclusion: Curcuminoid from turmeric (Curcuma longa L.) with mesoporous silica 
nanoparticles has an inhibitory effect against Staphylococcus epidermidis. 
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INTRODUCTION 
 
Staphylococcus epidermidis is a 
gram-positive bacteria from the genus 
Staphylococcus. Staphylococcus 
epidermidis is a coagulase-negative 
Staphylococcus, and it is the most normal 
flora in the human skin and mucous 
membrane(1,2). Infection due to coagulase-
negative staphylococci (CoNS) is a 
nosocomial infection that can cause 
infection on implanted medical devices, 
such as prostheses in the knee, 
cerebrospinal fluid shunts, central venous 
catheter, intravascular catheter, cardiac 
pacemaker, and urinary tract catheter 
especially in patients with very young or 
old age, or patients with 
immunocompromised conditions. About 
75% of infections caused by coagulase-
negative staphylococci and cases of 
bacteremia in medical device implants are 
caused by Staphylococcus epidermidis(1–6). 
Infection caused by Staphylococcus 
epidermidis is difficult to treat because 
Staphylococcus epidermidis can form 
biofilms on the surface of prosthetic 
devices that can protect bacteria from 
antibiotics and the immune system. There 
is a correlation between biofilms and the 
resistance of Staphylococcus epidermidis 
bacteria to several types of antibiotics 
(1,5,7,8). The research results by Gordon in 
2012 showed that out of 100 
Staphylococcus epidermidis bacteria 
isolated, 79% were resistant to Methicillin, 
while 98% were resistant to Penicillin(9). 
Indonesia is a tropical country that 
has the potential of plants that are 
hereditary used as herbal medicines (10). 
One of the traditional plants that have been 
studied and has an antibacterial effect is 
turmeric or Curcuma longa L (11). Turmeric 
is commonly used as a coloring agent, 
flavoring, and food deodorizer (12–14). In the 
turmeric rhizome, there is curcumin, which 
is a polyphenolic compound which is 
included in Curcuminoid which is 
hydrophobic. Curcumin content in turmeric 
has several benefits, besides being 
beneficial as an antibacterial, it can also be 
used as an antioxidant, anti-inflammatory, 
antiviral, antifungal, antiparasitic, anti-
allergic, antiarthritis, Alzheimer's 
treatment, anticancer, hepatoprotective, 
neuroprotective, nephroprotective, and 
anti-HIV(15,16).  
Curcumin inhibits bacterial cell 
proliferation and breaks bacterial cell 
walls, causing cell rupture which leads to 
bacterial cell death (11,17). Curcumin has a 
problem in the low level of solubility in 
water which then causes a decrease in 
absorption, increased metabolism, and 
increased excretion which causes low 
bioavailability of curcumin(11,18). 
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To overcome the low level of 
solubility and bioavailability of curcumin, 
nanoparticle-based drugs are developed. 
These drugs can increase bioavailability 
and solubility in water, and increase 
cellular uptake(11,14). Mesoporous silica 
nanoparticles have been studied and are 
known to have interesting properties, such 
as hydrophilic surface, longer blood 
circulation time, very low toxicity, and 
better absorption(19–21). Therefore, this 
study was conducted to determine 
inhibitory activity and kill Curcuminoid 
originating from Curcuma longa L. with 
mesoporous silica nanoparticles against 
Staphylococcus epidermidis bacteria, in the 
hope of being developed into an 
antibacterial candidate. 
 
METHODS 
 
This study used an experimental study 
with a nonequivalent control group design. 
This research was conducted in the 
Microbiology Laboratory of Faculty of 
Medicine, Research Laboratory Faculty of 
Pharmacy Widya Mandala Catholic 
University of Surabaya, and Laboratorium 
Mikrobiologi Klinik Balai Besar 
Laboratorium Kesehatan (BBLK) 
Surabaya. The population of this study was 
S. epidermidis bacteria. The samples taken 
were S. epidermidis ATCC 14990 obtained 
from the BBLK Clinical Microbiology 
Laboratory. The concentration of 
Curcuminoid with mesoporous silica 
nanoparticles used was 2000 - 32000 µg / 
mL.  
Preparation of Curcuminoid with 
Mesoporous Silica Nanoparticles  
Add 480 mg of Curcuminoid with 
mesoporous silica nanoparticles obtained 
from the Chemical Engineering 
Department into a test tube. Add 5 mL 
tween 20 to the test tube filled with 
Curcuminoid with mesoporous silica 
nanoparticles then mix until homogeneous 
using vortex. Curcuminoid with 
mesoporous silica nanoparticles solution 
was obtained with a concentration of 
96000 µg / mL. 
Preparation of Bacterial Suspension 
S. epidermidis ATCC 14990 was taken 
with a sterile ose and then suspended into a 
tube containing 5 mL 0.9% NaCl solution 
to obtain bacterial turbidity similar to 0.5 
McFarland standard turbidity on Mc 
Farland densitometer to obtain a bacterial 
suspension containing 1.5 x 108 CFU / mL. 
Antibacterial Test 
Antibacterial activity testing was 
performed by the microdilution method. 
This study was divided into a control group 
and a treatment group with a volume of 
each well of 150 µL. 
K1-4 = The control group consists of:  
K1 = Mueller Hinton Broth  
K2a-e = Mueller Hinton Broth + 
Curcuminoid with mesoporous silica 
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nanoparticles on concentration 2000 – 
32000 µg/mL 
K3 = Mueller Hinton Broth + S. 
epidermidis + Penicillin 
K4 = Mueller Hinton Broth + S. 
epidermidis + tween 20 
P0-5 = The treatment group consists of: 
P0 = Mueller Hinton Broth + S. 
epidermidis 
P1-5 = Mueller Hinton Broth + S. 
epidermidis + Curcuminoid with 
mesoporous silica nanoparticles on 
concentration 2000 – 32000 µg/mL.  
Then the microplate was incubated 
for 24 hours at 37 oC. After incubation, 
turbidity was observed by using a 
spectrophotometer to evaluate the optical 
density value. After that, the results of 
microdilution were planted in Mueller 
Hinton Agar and then incubated for 24 
hours at 37 oC to evaluate bacterial growth.  
 
RESULTS 
 
The optical density value (OD) on 
the spectrophotometer reading (Table 1) 
shows that the higher the concentration of 
Curcuminoid with mesoporous silica 
nanoparticles, the lower the value of OD. 
Concentration in the range 2000 - 32000 
µg / mL with the lowest concentration is at 
P1, and the highest concentration is at P5. 
Table 1. Results of optical density 
Curcuminoid with mesoporous silica 
nanoparticles values on a spectrophotometer 
Concentration x̅ ± SD 
P0 0,16 ± 0,026 
P1  0,23 ± 0,03 
P2 0,25 ± 0,038 
P3  0,22 ± 0,042 
P4 0,07 ± 0,028 
P5  0,01 ± 0,01 
 
In Figure 1 shows that the higher 
the concentration of Curcuminoid with 
mesoporous silica nanoparticles, the higher 
the percentage of inhibition to the 
Staphylococcus epidermidis bacteria. The 
highest percentage inhibition was at a 
concentration of 32000 µg / mL which was 
equal to 90%. 
Figure 1. Percentage of Curcuminoid with mesoporous silica nanoparticles inhibition S. epidermidis 
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In Figure 2 shows that after planting 
on MHA and incubating for 24 hours at 37 
oC, all bacteria in the treatment group grew 
on MHA. There was no bacterial growth in  
K1 and K2a - K2e. In the K3 there was no 
bacterial growth. In the K4 appears 
bacterial growth. 
Figure 2. Observation of treatment group (A), control of K2a - K2e (B), and control K1 - K4 (C) 
after growing on MHA and incubating for 24 hours at 37 oC.
 
DISCUSSION 
 
The results of this study show that 
Curcuminoid with mesoporous silica 
nanoparticles has an antibacterial effect on 
Staphylococcus epidermidis bacteria. Based 
on the results of observations on the 
spectrophotometer, it was shown that the 
higher the concentration of Curcuminoid 
with mesoporous silica nanoparticles would 
also be followed by a decrease in the value 
of OD. This means that more bacteria die if 
the concentration of Curcuminoid with 
mesoporous silica nanoparticles is 
increased(22).  
The calculation of the percentage of 
resistance to Staphylococcus epidermidis 
also shows a trend that increases along with 
the increase in the concentration of 
Curcuminoid with mesoporous silica 
nanoparticles. In this study found MIC 
Curcuminoid with mesoporous silica 
nanoparticles against Staphylococcus 
epidermidis located at a concentration of 
32000 µg/mL. Several factors are thought to 
play a role in influencing this study 
including the effectiveness of Curcuminoid 
as a single antibacterial preparation, 
thermolabile Curcuminoid properties, the 
pore size of mesoporous silica 
nanoparticles, and Curcuminoid release 
process from mesoporous silica 
nanoparticles. 
The effectiveness of Curcuminoid as a 
single antibacterial preparation is thought to 
be less effective when compared with water 
extract from turmeric rhizome as in the 
study conducted by Niamsa, N. (2009). 
Allegedly this is because, in addition to 
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containing Curcuminoid, water extract from 
turmeric rhizome also contains sequesters 
and isoflavones which have antibacterial 
effects(23–26). The thermolabile Curcuminoid 
properties are also thought to play a role in 
the occurrence of changes in the structure of 
Curcuminoid during the loading process 
into the pores of mesoporous silica 
nanoparticles that require heating at a 
temperature of 55 ° C. In a study conducted 
by Kharat (2017), the percentage of 
curcumin retention in fat emulsions in water 
will decrease with increasing temperature, 
the greatest decrease in retention of 
curcumin is found in heating at 55 ° C (27).  
Another factor that is thought to 
influence the results of this study is that the 
pore size of mesoporous silica nanoparticles 
that contain Curcuminoid is not uniform, 
causing a difference in the number of 
particles of Curcuminoid in the same 
measurement of concentration. This can 
cause differences in the effectiveness of 
Curcuminoid with mesoporous silica 
nanoparticles as antibacterial preparations. 
In this study, it was assumed that the release 
process of Curcuminoid from mesoporous 
silica nanoparticles was hampered so that it 
could affect the antibacterial effect of 
Curcuminoid. The blockage of curcuminoid 
release from mesoporous silica 
nanoparticles causes a longer time needed 
so that the Curcuminoid can be completely 
released and interact with bacterial cells to 
cause an antibacterial effect. 
The antibacterial mechanism of 
Curcuminoid with mesoporous silica 
nanoparticles is thought to originate from 
the ability of Curcuminoid to inhibit 
bacterial cell proliferation and has the 
ability to breaks bacterial cell walls causing 
bacterial cell rupture which leads to 
bacterial cell death(12,15). Curcuminoid also 
has an antibiofilm effect, especially in 
bacteria that can form biofilms such as the 
Staphylococcus epidermidis bacteria. 
Curcuminoid inhibits the expression of 
biofilm-forming and quorum sensing genes 
from bacteria. The ability of bacteria to 
form a biofilm depends on quorum sensing, 
such as the ability to produce alginate, 
motility, and moving in a colony(12,15). 
Turmeric (Curcuma longa L). also has the 
ability to reduce the attachment of bacteria 
to the surface of the substrate and reduce 
the adhesion to the biofilm surface so that 
microorganisms are more difficult to attach 
to previously formed biofilms. 
 
CONCLUSION 
 
Based on the results of the study it can 
be concluded that Curcuminoid with 
mesoporous silica nanoparticles has an 
inhibitory effect on the growth of 
Staphylococcus epidermidis bacteria at a 
concentration of 32000 µg / mL.
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